Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 437

1.

Low reproducibility of the diagnosis of subsegmental pulmonary embolism in symptomatic patients.

Pesavento R, de Conti G, Motta R, Ceccato D, Baro E, Prandoni P.

Thromb Res. 2018 Dec 21;175:6-7. doi: 10.1016/j.thromres.2018.12.022. [Epub ahead of print] No abstract available.

PMID:
30660947
2.

Accuracy of age-adjusted D-dimer to rule out deep vein thrombosis in the elderly.

Riva N, Righini M, Camporese G, Iotti M, Bucherini E, Kamphuisen PW, Verhamme P, Douketis JD, Tonello C, Prandoni P, Ageno W; PALLADIO Study Investigators.

Thromb Res. 2019 Jan 3;174:148-150. doi: 10.1016/j.thromres.2018.12.024. [Epub ahead of print] No abstract available.

PMID:
30634165
3.

Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry.

Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Pieper KS, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators.

Thromb Haemost. 2018 Dec 28. doi: 10.1055/s-0038-1676611. [Epub ahead of print]

PMID:
30593086
4.

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review.

van der Wall SJ, van der Pol LM, Ende-Verhaar YM, Cannegieter SC, Schulman S, Prandoni P, Rodger M, Huisman MV, Klok FA.

Eur Respir Rev. 2018 Nov 28;27(150). pii: 180094. doi: 10.1183/16000617.0094-2018. Print 2018 Dec 31. Review.

5.

Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions.

Riess H, Prandoni P, Harder S, Kreher S, Bauersachs R.

Crit Rev Oncol Hematol. 2018 Dec;132:169-179. doi: 10.1016/j.critrevonc.2018.09.015. Epub 2018 Sep 29. Review.

PMID:
30447923
6.

Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis.

Amin EE, Ten Cate-Hoek AJ, Bouman AC, Meijer K, Tick L, Middeldorp S, Mostard G, Ten Wolde M, van den Heiligenberg S, van Wissen S, van de Poel M, Villalta S, Serné E, Otten HM, Klappe E, Prandoni P, Prins MH, Ten Cate H, Joore MA.

Lancet Haematol. 2018 Nov;5(11):e512-e519. doi: 10.1016/S2352-3026(18)30151-0. Epub 2018 Oct 9.

PMID:
30314712
7.

Retinal vein thrombosis and risk of occult cancer: A nationwide cohort study.

Hansen AT, Veres K, Prandoni P, Adelborg K, Sørensen HT.

Cancer Med. 2018 Nov;7(11):5789-5795. doi: 10.1002/cam4.1803. Epub 2018 Sep 27.

8.

Health-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial Population.

Wells PS, Prins MH, Beyer-Westendorf J, Lensing AWA, Haskell L, Levitan B, Laliberté F, Ashton V, Xiao Y, Lejeune D, Crivera C, Lefebvre P, Zhao Q, Yuan Z, Schein J, Prandoni P.

Chest. 2018 Dec;154(6):1371-1378. doi: 10.1016/j.chest.2018.08.1059. Epub 2018 Sep 7.

9.

The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.

Ten Cate H, Lensing AWA, Weitz JI, Middeldorp S, Beyer-Westendorf J, Kubitza D, Brighton T, Raskob GE, Mismetti P, Prandoni P, Gebel M, Prins MH.

Thromb Res. 2018 Oct;170:75-83. doi: 10.1016/j.thromres.2018.08.008. Epub 2018 Aug 15.

PMID:
30121419
10.

Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.

Prandoni P, Lensing AWA, Prins MH, Gebel M, Pap AF, Homering M, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Cohen AT, Davidson BL, van Bellen B, Verhamme P, Wells PS, Yuan Z, Levitan B, Weitz JI.

Thromb Res. 2018 Aug;168:121-129. doi: 10.1016/j.thromres.2018.06.009. Epub 2018 Jul 10.

PMID:
30064683
11.

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.

Palareti G, Antonucci E, Mastroiacovo D, Ageno W, Pengo V, Poli D, Testa S, Tosetto A, Prandoni P.

J Thromb Haemost. 2018 Oct;16(10):1994-2002. doi: 10.1111/jth.14253. Epub 2018 Aug 24.

PMID:
30059189
12.

Development and Validation of a Practical Two-Step Prediction Model and Clinical Risk Score for Post-Thrombotic Syndrome.

Amin EE, van Kuijk SMJ, Joore MA, Prandoni P, Ten Cate H, Ten Cate-Hoek AJ.

Thromb Haemost. 2018 Jul;118(7):1242-1249. doi: 10.1055/s-0038-1655743. Epub 2018 Jun 4.

PMID:
29864783
13.

Clinical and economic impact of compression in the acute phase of deep vein thrombosis.

Amin EE, Joore MA, Ten Cate H, Meijer K, Tick LW, Middeldorp S, Mostard GJM, Ten Wolde M, van den Heiligenberg SM, van Wissen S, van de Poel MHW, Villalta S, Serné EH, Otten HM, Klappe EH, Prandoni P, Ten Cate-Hoek AJ.

J Thromb Haemost. 2018 Jun 1. doi: 10.1111/jth.14163. [Epub ahead of print]

PMID:
29856509
14.

Risk of recurrent venous thromboembolism according to baseline risk factor profiles.

Prins MH, Lensing AWA, Prandoni P, Wells PS, Verhamme P, Beyer-Westendorf J, Bauersachs R, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Kakkar AK, van Bellen B, Pap AF, Homering M, Tamm M, Weitz JI.

Blood Adv. 2018 Apr 10;2(7):788-796. doi: 10.1182/bloodadvances.2018017160.

15.

A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism.

Bova C, Vanni S, Prandoni P, Morello F, Dentali F, Bernardi E, Mumoli N, Bucherini E, Barbar S, Picariello C, Enea I, Pesavento R, Bottino F, Jiménez D; Bova Score Validation Study Investigators.

Thromb Res. 2018 May;165:107-111. doi: 10.1016/j.thromres.2018.04.002. Epub 2018 Apr 4.

PMID:
29631073
16.

Prevention and treatment of the chronic thromboembolic pulmonary hypertension.

Pesavento R, Prandoni P.

Thromb Res. 2018 Apr;164:150-156. doi: 10.1016/j.thromres.2018.02.149. Epub 2018 Mar 2.

PMID:
29526325
17.

Challenges in the diagnosis of sub-segmental pulmonary embolism in symptomatic patients: a case report.

Milan M, Sarolo L, Cozzolino P, Prandoni P.

Aging Clin Exp Res. 2018 Oct;30(10):1251-1253. doi: 10.1007/s40520-018-0901-5. Epub 2018 Feb 1. No abstract available.

PMID:
29392575
18.

Predictors of Post-Thrombotic Ulcer after Acute DVT: The RIETE Registry.

Galanaud JP, Bertoletti L, Amitrano M, Fernández-Capitán C, Pedrajas JM, Rosa V, Barrón M, Lorenzo A, Madridano O, Quéré I, Kahn SR, Prandoni P, Monreal M; RIETE registry investigators.

Thromb Haemost. 2018 Feb;118(2):320-328. doi: 10.1160/TH17-08-0598. Epub 2018 Jan 29.

PMID:
29378357
19.

Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE).

Bikdeli B, Jimenez D, Hawkins M, Ortíz S, Prandoni P, Brenner B, Decousus H, Masoudi FA, Trujillo-Santos J, Krumholz HM, Monreal M; RIETE Investigators.

Thromb Haemost. 2018 Jan;118(1):214-224. doi: 10.1160/TH17-07-0511. Epub 2018 Jan 5.

20.

Pregnancy-related venous thromboembolism and risk of occult cancer.

Hansen AT, Veres K, Horváth-Puhó E, Ehrenstein V, Prandoni P, Sørensen HT.

Blood Adv. 2017 Oct 19;1(23):2059-2062. doi: 10.1182/bloodadvances.2017010231. eCollection 2017 Oct 24.

Supplemental Content

Loading ...
Support Center